In Vitro Activities of 15 Antifungal Drugs against a Large Collection of Clinical Isolates of Microsporum canis.

Clicks: 379
ID: 4756
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #16 of 59 articles by views in Mycoses

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Microsporum canis is a zoophilic species, found to be the most frequently isolated species in animals. M. canis causes sporadic outbreaks of infections in humans, such as the one that occurred in Canada, where more than 1,000 human cases were detected over an 8-year period. Despite the medical importance of M. canis infections, there are limited in vitro data on the antifungal susceptibility to antifungal drugs, including new generation triazoles and imidazoles.The aim of the current study was to comprehensively evaluate the in vitro activity of new azoles and comparator drugs against a large panel of M. canis isolates collected in Iran, France, and Turkey from patients and animals with dermatophytosis using a microdilution assay.The in vitro susceptibility to novel triazoles and imidazoles was compared to that of other antifungal drugs using a large collection of M. canis clinical isolates (n = 208) obtained from patients and animals with dermatophytosis in Iran, France, and Turkey.All isolates exhibited high susceptibility to the majority of the tested antifungal agents.FDA-approved antifungal drugs, i.e., luliconazole, efinaconazole, and lanoconazole, showed the highest antifungal activity and should be promising candidates for the treatment of dermatophytosis caused by M. canis. However, their therapeutic effectiveness remains to be determined in clinical settings. This article is protected by copyright. All rights reserved.
Reference Key
abastabar2019inmycoses Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mahdi Abastabar, Ali Jedi, Jacques Guillot, Macit Ilkit, Samaneh Eidi, Mohammad Taghi Hedayati, Tahereh Shokohi, Roshanak Daie Ghazvini, Ali Rezaei-Matehkolaei, Farzad Katiraee, Javad Javidnia, Bahram Ahmadi, Hamid Badali
Are you one of these authors? Claim your profile
Journal Mycoses
Year 2019
DOI
10.1111/myc.12986
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.